Sionna Therapeutics, Inc.
NASDAQ:SIONBiotechnology
+$0.68 today
- Market cap
- $134.35M
- Beta
- 1.29
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.90
Volume 0.52M
Average 0.39M
SION Other Working Capital
Cash effect of changes in other operating assets and liabilities.
Sionna Therapeutics, Inc.NASDAQ: SION
Other Working Capital · Q1 FY2026 · quarter ended Mar 2026
Other working capital declines year over year
Q1 FY2026 other working capital of $3.27M (cash outflow) fell 39.6% year over year, ahead of the -98.0% change in trailing-twelve-month other working capital.
Context
- Other working capital increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -39.6% holds above the trailing-twelve-month pace of -98.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Working Capital history
USD · from the cash flow
- Latest · FY2025
- (2.24M) USD
- Year-over-year change
- +36.9%
| Period | Period end | Other Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.24M) | +36.9% |
| FY2024 | 2024-12-31 | (3.54M) | -274.8% |
| FY2023 | 2023-12-31 | (945K) | -122.1% |
| FY2022 | 2022-12-31 | 4.28M | — |
Other Working Capital vs competitors
How SION compares with its peers on the latest reported figures
- SION's LTM Mar 2026 other working capital of $94K is the smallest of the 11 companies compared; the peer median is $6.31M.
- Its year-over-year change of -98.0% is the 9th highest of 11, against a peer median of +76.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $46.14M | +312.2% | +7.9% | 213.5% | |
| LTM Jun 2026 | $41.72M | -258.5% | — | — | |
| LTM Sep 2026 | $37.56M | +3020.7% | — | 55.4% | |
| LTM Mar 2026 | $22.94M | +43.6% | — | 7.3% | |
| LTM Mar 2026 | $15.82M | +109.4% | +6.8% | 3.7% | |
| LTM Sep 2026 | $7.13M | +411.7% | — | 6362.5% | |
| LTM Sep 2026 | $5.5M | +135.4% | — | — | |
| LTM Sep 2026 | $4.23M | -71.9% | +59.3% | 1.6% | |
| LTM Mar 2026 | $4.17M | +9.3% | — | 20.8% | |
| LTM Jun 2026 | $2.24M | -482.1% | — | — | |
| LTM Mar 2026 | $94K | -98.0% | — | — | |
| Peer median (excluding SION) | $6.31M | +76.5% | +7.9% | 20.8% | |
Competitors are the stored peer set for SION. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Sionna Therapeutics, Inc.
NASDAQ:SION
Intrinsic Alpha fair value
Locked
Current Price
$2.97
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.